TYPES OF TARGETED
THERAPY DRUGS
Two patients with the same cancer type may be on completely different targeted therapy categories because their tumours have different molecular drivers. The drug follows from the mutation profile.
Targeted Therapy Drug Classes at a Glance
| Drug Class | Mechanism | Route | Key Examples | Key Cancer Types |
|---|---|---|---|---|
| Tyrosine Kinase Inhibitors (TKIs) | Block kinase proteins from passing growth signals inside cells | Oral pill | Osimertinib, alectinib, imatinib | Lung (EGFR/ALK), CML, GIST |
| Monoclonal Antibodies | Bind to surface targets; block activation or recruit immune destruction | IV infusion | Trastuzumab, cetuximab, bevacizumab | Breast, colorectal, lung |
| Antibody-Drug Conjugates (ADCs) | Antibody delivers toxic payload directly to cancer cells | IV infusion | Trastuzumab deruxtecan, T-DM1 | Breast, gastric, lung |
| PARP Inhibitors | Block DNA repair pathway BRCA-mutated cancers depend on | Oral pill | Olaparib, niraparib, rucaparib | Ovarian, breast, prostate, pancreatic |
| CDK4/6 Inhibitors | Block proteins driving the cell division cycle | Oral pill | Palbociclib, ribociclib, abemaciclib | HR+ breast cancer |
| mTOR Inhibitors | Disrupt pathway regulating cell growth and metabolism | Oral pill | Everolimus, temsirolimus | Kidney, HR+ breast cancer |
| Proteasome Inhibitors | Disrupt protein disposal causing lethal cell stress | IV or subcutaneous | Bortezomib, carfilzomib | Multiple myeloma |
Frequently Asked Questions
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Questions About Which Targeted Drug Class Applies to Your Diagnosis?
CancerFax reviews your molecular profile to identify which targeted therapy categories are relevant for your specific cancer.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.